Deloitte July 15, 2024
Jessica Syslo, Ismail Kassam, Christi Hall, Leena Gupta, Natasha Elsner, Apoorva Singh

Biopharma’s early digitization efforts showcase the need to adopt a more comprehensive development strategy for the supply chain workforce and other functions

Many biopharma companies are digitally transforming their supply chains1 to help prepare for future challenges. Over the past year, we have explored how digitizing processes and information can help supply chains become more resilient and sustainable. In this fourth and final installment of our biopharma supply chain series, we turn our attention to the transformation’s impact on the workforce. Workers are not just being affected by this change—they are the agents enabling and implementing it, so they must adapt to using the latest technologies in their roles.

In 2023, the Deloitte Center for Health Solutions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Survey / Study, Technology, Trends
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Share This Article